About: Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 2000

Attributes	Values
rdf:type	Item
description	наукова стаття, опублікована в червні 2000 (uk) im Juni 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 2000 (ast) scientific article published on 01 June 2000 (en)
publication date	wds:Q64380720-3E6F6FB3-C90B-49C2-8624-23AF081EB434
publication date	2000-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64380720-64E514D5-388C-4A18-828C-1D458B93180A
language of work or name	English
author name string	wds:Q64380720-4A5AA0D9-C363-4A4B-996E-667EFC76680F wds:Q64380720-6D9EE67A-048E-42C1-A5A6-36CEB910D361 wds:Q64380720-849F8E62-77BB-44A7-947C-80ED4067CB8E wds:Q64380720-858D7F7E-20D9-47CD-9545-972C4E3EA3F8 wds:Q64380720-867974B1-4D1C-4537-A4E7-DBA0FBDDDC94 wds:Q64380720-8842DCD0-5A11-4E12-9438-5CEF18D6EE1F wds:Q64380720-AAE251AD-A6F6-4759-8D54-CBE9508873A3
author name string	J Li R L Simmons T R Billiar S C Watkins E Tzeng S Nie A Lizonova
rdfs:label	Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate (en)
skos:prefLabel	Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate (en)
name	Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate (en)
author	wds:Q64380720-3893F65D-6B43-460E-A05F-BFD8A45C358D wds:Q64380720-7D3995B9-F519-4469-B10E-9728765F9D8D
author	Melina R. Kibbe Imre Kovesdi
title	wds:Q64380720-3AB33353-27C9-43B4-849F-5D5BCD78ABE6
title	Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate (en)
page(s)	wds:Q64380720-9DAF0877-CE0F-4730-ABEB-F04377671A81
page(s)	1214-1228
instance of	wds:Q64380720-A81B02DE-26F1-4064-A935-17CA5345FC92
instance of	scholarly article
PubMed ID	wds:Q64380720-105E8805-8525-46F9-9A93-CCB28E0D7136
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10842159
PubMed ID	10842159
published in	wds:Q64380720-40CECAA4-453C-474B-8616-CC81C2F96537
published in	Journal of Vascular Surgery
issue	wds:Q64380720-65BD3EEA-46A0-42F4-9658-6C084CB21EEF
volume	wds:Q64380720-9F9CCB1E-CF2D-4193-B3A7-4AB04CDF0DF9
issue	6
volume	31
DOI	wds:Q64380720-D9C8FE8B-2344-4F60-A3B5-3D8E6351778F
DOI	http://dx.doi.org/10.1067/MVA.2000.105006
DOI	10.1067/MVA.2000.105006
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64380720
is cites work of	Reactive oxygen and nitrogen species in pulmonary hypertension Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia Effects of nitric oxide on cell proliferation: novel insights Cytokine-induced beta-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide Beneficial effect of a short-acting NO donor for the prevention of neointimal hyperplasia. Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10 Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide Overexpression of mutated IκBα inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction Activation of Protein Kinase G (PKG) Reduces Neointimal Hyperplasia, Inhibits Platelet Aggregation, and Facilitates Re-endothelialization Nitric oxide inhibits the proliferation of murine microglial MG5 cells by a mechanism involving p21 but independent of p53 and cyclic guanosine monophosphate Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model Nitric oxide increases lysine 48-linked ubiquitination following arterial injury. Xanthine Oxidoreductase Function Contributes to Normal Wound Healing Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors Recent developments in gene therapy for cardiac disease Proliferation of macrophages due to the inhibition of inducible nitric oxide synthesis by oxidized low-density lipoproteins. Adjacent sequence controls the response polarity of nitric oxide-sensitive Sp factor binding sites High glucose blocks the effects of estradiol on human vascular cell growth: differential interaction with estradiol and raloxifene The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sex Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells Sex-based differential regulation of oxidative stress in the vasculature by nitric oxide The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status Effect of nitric oxide on mitogen-activated protein kinases in neonatal pulmonary vascular smooth muscle Nitric oxide is a signaling molecule that regulates gene expression Role of metabolic environment on nitric oxide mediated inhibition of neointimal hyperplasia in type 1 and type 2 diabetes Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia NF-κB Activity Initiates Human ESC-Derived Neural Progenitor Cell Differentiation by Inducing a Metabolic Maturation Program. Systemic vasoprotection by inhaled carbon monoxide is mediated through prolonged alterations in monocyte/macrophage function 1H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures
is cites work of	wds:Q33814725-4D16AD52-BE69-4130-8CF9-83EB79208C8F wds:Q36973472-128E3652-C4EA-4AD6-B45F-B23D12D7A87E wds:Q37408405-9D6708AB-E67D-4475-AD44-D37188953BF9 wds:Q43459170-1E4C1B33-ADC8-42CE-8C5A-63F8B75741D7 wds:Q40555973-4889481B-BEAD-407A-A265-D945D0ABD939 wds:Q83745461-3D4E91CA-1F5C-4C6B-93F3-95DF2D27E884 wds:Q34784965-FC664A3F-C9EE-4FF3-AF92-DA55D5069D6E wds:Q36106439-B4C80F55-1C37-48A6-B934-3CE0866B42BA wds:Q36497132-A0A09531-EC55-4441-A6A0-2A19BE906B02

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software